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 Background: HSP60-related immunological activities are found in normal-pressure glaucoma (NPG) patients, in whom an el-
evated intraocular pressure (IOP) found in primary open-angle glaucoma (POAG) is not observed. HSP60 was 
found in POAG and NPG patients, while anti-HSP60 level was mainly found to be higher in NPG patients. The 
purpose of this study was to compare the percentages of Th cells and levels of related cytokines, attempting 
to provide evidence to explain this discrepancy.
 Material/Methods: Blood samples from POAG, NPG, and normal control (NC) groups were collected and peripheral blood mono-
cytes were isolated and cultured with or without the stimulation of HSP60. Flow cytometry and enzyme-linked 
immunosorbent assay were used to assess the percentages of Th1, Th2, Th17, and Treg cells, as well as HSP60 
antibody levels and related cytokine levels, before and after culture.
 Results: Significantly higher titers of anti-HSP60 were observed only in NPG patients. Comparable Th1 and Th2 cell fre-
quencies, IL-4 level, and IFN-g level were found in POAG and NPG patients, while higher Treg cell frequency 
was only found in POAG patients. After culturing with HSP60, increased Th2 frequencies and decreased Th1 
frequencies were observed in the POAG, NPG, and NC groups, while increased Treg frequency was only identi-
fied in the POAG and NC groups.
 Conclusions: Different Th cell patterns were observed among POAG, NPG, and NC groups. Lack of induction of Treg cells and 
imbalance of the pro-inflammatory and anti-inflammatory response patterns of Th cells exist in some NPG 
patients.
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Background
Glaucoma is the leading irreversible eye disease in the world. 
The number of glaucoma patients will exceed 76 million by 
2020, among which over 11 million will be bilaterally blind [1,2]. 
Elevation of intraocular pressure (IOP) is regarded the most im-
portant risk factor for the development of glaucoma, and IOP 
control is for now the only effective and well-accepted treat-
ment. However, approximately 30% of glaucoma patients pres-
ent without elevation of IOP [3–5]. Over 90% of Japanese open-
angle glaucoma patients have normal IOP [6]. The Baltimore 
Eye Survey revealed that 20% of their POAG patients had an 
IOP of less than 21 mmHg on each of their first 3 visits, sug-
gesting that normal-pressure eye disease may be more com-
mon than previously thought [3]. The efficacy of IOP control 
in normal-pressure glaucoma patients (NPG) has been report-
ed; however, progression is still observed in many cases after 
lowering IOP. The existence of NPG patients has spurred fur-
ther research to explore other possible risk factors for glau-
coma to find effective treatments [7].
Accumulating evidence shows that heat-shock protein (HSP) 
60-related autoimmunity is involved in many diseases, includ-
ing inflammatory arthritis, type 1 diabetes, and multiple sclero-
sis [8–10], as well as in the development of NPG. Higher levels 
of HSP60 and its antibody have been found in the retina and 
serum/aqueous fluid of NPG patients, indicating involvement 
of HSP60-specific autoimmune activity [11–14]. Investigation 
of the association between involvement of HSP autoimmune 
activity and the signature event of glaucoma, which is retinal 
ganglion cell (RGC) loss, shows that HSP antibody can lead to 
changes in regulatory proteins and cytoskeleton of RGCs [15]. 
Furthermore, an experimental autoimmune glaucoma model 
has been successfully established and demonstrated that im-
munization with HSP60 can induce upregulated HSP60 anti-
body and significant RGC loss [16,17]. Although HSP60-specific 
autoimmune activity was observed in POAG and NPG, some 
findings suggest that the ways in which HSP autoimmunity is 
involved differ between POAG and NPG. Approximately 30% 
of patients with NPG have 1 or more immune-related diseas-
es, which is not observed in POAG [18]. Unlike NPG, progres-
sion is limited in most cases of POAG if IOP is under control. 
More importantly, a higher titer of autoantibody to HSP60 was 
mainly found in patients with normal-pressure glaucoma, and 
less or no significant difference was found between POAG and 
control subjects in some studies [19].
Balanced responses of both pro- and anti-inflammatory Th 
cells are essential to prevent an immune response from turn-
ing into autoimmune disease. Recently, imbalances have been 
reported to be responsible for some autoimmune diseases, 
such as multiple sclerosis and type 1 diabetes, which are also 
associated with HSP60 [20,21]. Therefore, in this study, after 
evaluating the levels of HSP60 and its antibody in our POAG 
and NPG patients, we evaluated the percentages of the main 
Th cells involved in pro-inflammatory and anti-inflammatory 
responses, attempting to explain the discrepancy with regard 
to the presence of HSP60 and higher titers of HSP60 antibody 
in NPG patients compared to POAG patients.
Material and Methods
Study participants
This study was approved by the Institutional Review Board of 
our hospital, and carried out in accordance with the Declaration 
of Helsinki. After obtaining written informed consent, periph-
eral blood was collected from each participant, including glau-
comatous patients and healthy volunteers.
Consecutive patients with POAG and NPG visiting Shanghai 
Ninth People’s Hospital between October 2013 and April 2015 
were considered for inclusion in this study. Patients were fol-
lowed clinically by one of the authors for a minimum of 2 
years and received ophthalmologic examinations at least 4 
times yearly.
The inclusion criteria for POAG consists of the presence of 
open iridocorneal angles, IOP higher than 21 mmHg, charac-
teristically glaucomatous changes in visual fields, optic nerve 
cupping, retinal nerve fiber layer thinning, and the absence 
of other possible causes of optic neuropathy. Inclusion crite-
ria for NPG are the same as for POAG except that no evidence 
showed IOP exceeded 21 mmHg, confirmed at least twice by 
24-h IOP measurements. Normal control subjects had neither 
glaucoma nor any other ocular disease.
Exclusion criteria for the POAG and NPG candidates includ-
ed: a history of any other ocular disease; use of contact lens-
es; ophthalmic surgical procedures or intraocular laser sur-
gery in the past 1 year before this study; and a history of any 
kind of immunologic disease and immune-mediated disorder, 
including inflammation within the last 6 months, and cancer. 
Exclusion criteria for the NC group were the same as for the 
other 2 groups.
We screened 174 patients with POAG or NPG, as well as 40 
healthy volunteers, during the study period. All candidates un-
derwent thorough ocular examinations, including visual acu-
ity, slit-lamp biomicroscopy, ophthalmoscopy, Goldmann ap-
planation tonometry, visual field testing, and optical coherence 
topography. Results of examinations of the more severe eye 
were included in the comparison if both eyes were diagnosed 
as having glaucoma.
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Blood sampling
We collected 6 mL of fresh peripheral blood into Vacutainer 
tubes (Becton Dickinson Systems, San Jose, CA) containing 
EDTA from each participant. After serum was isolated and 
stored at –80°, peripheral blood mononuclear cells (PBMCs) 
were isolated with the Ficoll-Hypaque density gradient (den-
sity 1.077; Biochrom, Berlin, Germany) centrifugation meth-
od. Isolated PBMCs were then resuspended in RPMI 1640 
medium (Gibco, Grand Island, NY) that contained 2 mmol/L 
L-glutamine, 1 mmol/L sodium pyruvate, 100 μg/mL strepto-
mycin, 100 units/mL penicillin, and 10% heat-inactivated fe-
tal bovine serum.
Cell culture and stimulation
Isolated PBMCs were plated at a density of 1.0×106/well and 
cultured in the absence or presence of HSP60 (2.5 ng/ml, Enzo 
Life Sciences Inc., Farmingdale, NY) for 2 days. Cells were cul-
tured and harvested for flow cytometry for a direct culture 
assay as described by Kepitein and de Kleer [22,23], in which 
the peripheral blood monocytes were isolated and cultured 
with or without the stimulation of HSP60, and at different 
time points of culture, monocytes were collected for flow cy-
tometry analysis.
Flow cytometry
Prior to Th1, Th2, and Th17 analysis, cells were first stimulated 
for 5 h with a cell stimulation cocktail, which included protein 
transport inhibitors Phorbol 12-myristate 13-acetate (PMA), 
ionomycin, Brefeldin A, and monensin (eBioscience, San Diego, 
CA), according to the manufacturer’s protocol. Then, cells were 
extracellularly stained with anti-human CD4 antibody, consec-
utively fixed and permeabilized (BD Biosciences, San Jose, CA, 
USA), and intracellularly stained with anti-human interferon-g, 
interleukin (IL)-4, and IL-17 antibody (eBioscience, San Diego, 
CA). For Tregs analysis, no stimulation with cell stimulation 
cocktail was needed. Monoclonal antibodies (mAbs) specific 
for anti-human CD4 and CD25 were used for surface staining, 
and anti-human FoxP3 antibody (eBioscience, San Diego, CA) 
was used for intracellular staining after fixation and perme-
abilization (eBioscience, San Diego, CA). Data were acquired 
using a FACS Calibur system (BD Biosciences) and analyzed 
by FlowJo software (Tree Star, Inc.).
Enzyme-linked immunosorbent assay
Serum HSP60 antibody titers were measured using an in-
house enzyme-linked immunosorbent assay (ELISA) described 
by Ghayour-Mobarhan [23]. Briefly, 96-well micro-titer plates 
(Costar, Corning, NY) were coated with 100 ng per well of low-
endotoxin recombinant human HSP60 (Enzo Life Sciences Inc., 
Farmingdale, NY) dissolved in 100 μl carbonate buffer, and in-
cubated overnight at 4°C under humidified conditions. The 
wells were then washed 3 times with phosphate-buffered sa-
line (PBS) containing 0.05% Tween-20 (PBST). Non-specific 
binding was reduced by blocking each well with 10% normal 
goat serum in PBS, and 200 μl was added to each well, and 
incubated overnight at 4°C under humidified conditions. Wells 
were washed 3 times with PBS. Serum was diluted 1: 30 with 
1% goat serum in PBS, and 100 μl was added to the each well 
in duplicate and then incubated for 2 h at room temperature. 
After washing 3 times in PBST, 100 μl peroxide conjugated-
goat anti-human IgG (BD Biosciences, San Jose, CA) diluted 1: 
5000 with 1% goat serum in PBS was added to each well and 
incubated for 45 min at room temperature. After washing 3 
times in PBST and 2 times in PBS, 100 μl of tetramethylben-
zidine (TMB) substrate (100 μl of 6 mg/ml TMB in DMSO was 
added to 10 ml of 50 mM acetate buffer, pH 4.5) was add-
ed per well, and the plates were incubated for 10 min in the 
dark at room temperature. Then, 100 ml 2M H2SO4 was added 
to each well to stop the reaction. Optical density values were 
read at 450 nm as a reference length.
Serum levels of cytokines, including IFN-g, IL-4, IL-10, IL-17, 
and TGF-b1, were measured with ELISA kits (eBioscience, San 
Diego, CA) according to the manufacturer’s protocols.
Statistical analysis
Analyses were performed using SPSS software (version 17.0, 
SPSS, Chicago, IL). The differences in the results of ophthal-
mic examinations between POAG and NPG groups were cal-
culated using the t test, signed-rank test, or chi-square test. 
One-way analysis of variance with Bonferroni post hoc analy-
sis was used when comparing results of ELISA and flow cytom-
etry. P values <0.05 were considered statistically significant.
Results
Subjects
Finally, 35 patients were included in the POAG group, 19 pa-
tients in the NPG group, and 27 normal participants in the 
NC group. Demographic and clinical information of patients 
is shown in Table 1. All 3 groups are age- and sex-matched.
Higher antibody titers were found in NPG group
Controversial results have been obtained in different studies 
with regard to the level of HSP60 antibody in POAG, suggest-
ing the HSP60 antibody level might vary in different groups 
of POAG patients. Therefore, we tested the HSP60 antibody 
level in our patients and based the subsequent analysis on 
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the results. The titer of anti-HSP60 antibody was measured 
using an in-house ELISA within 1 week after the serum was 
collected and stored at –80°. Serum titer of anti-HSP60 anti-
body was significantly higher in NPG patients than in POAG 
patients or normal participants (Figure 1), indicating that in 
these 3 groups of subjects, higher level of anti-HSP60 was 
mainly found in NPG, and anti-HSP60 level was not higher in 
POAG, compared to normal controls.
Imbalance between pro- and anti-inflammatory responses 
of Th cells in POAG and NPG
It has been confirmed by previous reports that elevated ex-
pression of HSP60 was found in retinas of both POAG and 
NPG patients, which means both group of patients were ex-
posed to the antigen HSP60. Since we also observed in our 
patients that the anti-HSP60 level was only higher in the NPG 
group, we hypothesized that after the exposure to HSP60, dif-
ferent immune events in POAG and NPG may occur and lead 
POAG (n=35) NPG (n=19) p-Value
Gender (Male: Female) 26: 9 14: 5 0.962*
Age (years) 41.23±11.42 45.89±9.28 0.133**
Use of prostaglandin analogs 33 (94.29%) 16 (84.21%) 0.227 *
IOP (mmHg) 18 (16–22) 15 (14–17) 0.002***
C/D ratio 0.9 (0.8–0.9) 0.8 (0.8–0.9) 0.970***
Table 1. Comparison of demographic and clinical data of POAG and NPG patients.
* Chi-square test; ** Student’s t-test, data are expressed as means and standard deviations; *** Wilcoxon rank sum test, data are 
expressed as medians and interquartile ranges; POAG – primary open angle glaucoma; NPG – normal pressure glaucoma; 
IOP – intraocular pressure; C/D ratio – cup-to-disc ratio.
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Figure 1.  Comparison of serum levels of anti-HSP60, IFN-g, IL-4, IL-17A, TGF-b1, and IL-10 between the primary open-angle glaucoma 
(POAG) group, the normal-pressure glaucoma (NPG) group, and the normal control (NC) group. (A) The absorbance of anti-
HSP60 was higher in the NPG group than in the NC group (P<0.05). No significant difference was found between the POAG 
and NC groups. (B) Serum levels of IFN-g were lower in the POAG and NPG groups (P<0.05). (C) The levels of IL-17A were 
lower in the POAG and NPG groups, and the difference was significant between POAG and NC groups (P<0.05). (D) Serum 
level of IL-4 was significant higher in the NPG group than in the NC group (P<0.05). The elevation of IL-4 was not significant 
in the POAG group compared to the NC group (P>0.05). (E) The levels of TGF-b1 were significantly higher in the POAG and 
NPG groups (P<0.05). (F) No significant difference in IL-10 level was observed between groups. Dark blue column: POAG 
group; light blue column: NPG group; white column: NC group. Statistical significance was analyzed using the t test. * P <0.05.
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to differences in antibody reactivity. Imbalance between pro- 
and anti-inflammatory responses of Th cells is associated with 
HSP60-related autoimmune diseases, so we evaluated the fre-
quencies of Th cells and levels of related cytokines.
Circulating pro-inflammatory Th cell frequencies
Th2 frequency was increased in both POAG and NPG patients.
The proportion of Th2 cells is expressed as the percentage of 
all CD4+ T cells. The frequency of Th2 cells was evidently in-
creased in the peripheral blood of patients in the POAG and NPG 
groups compared to the NC group (POAG group: 0.849±0.299; 
NPG group: 0.726±0.227; NC group: 0.507±0.18; p=0.000; 
Figure 2). No significant difference was found between the 
POAG and NPG group (p>0.05).
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Figure 2.  Comparison of peripheral frequencies of Th1 (CD4+IFN-g+ T cells), Th2 (CD4+IL-4+ T cells), Th17 (CD4+IL-17A+ T cells), and Treg 
(CD4+CD25+Foxp3+ T cells) between the primary open-angle glaucoma (POAG) group, the normal-pressure glaucoma (NPG) 
group, and the normal control (NC) group. (A–D) Representative experiments of the frequencies of Th1 and Th17 cells and 
comparison between groups. Frequencies of Th1 cells were lower in the POAG and NPG groups compared to the NC group. The 
difference was significant between the POAG and NC groups (P<0.05). No significant difference in the frequencies of Th17 cells 
was observed between groups. (E–H) Representative experiments on the frequencies of Th2 cells and comparison between 
groups. Frequencies of Th2 cells were significantly higher in the POAG and NPG groups compared to the NC group (P<0.05). 
(I–L) Representative experiments on the frequencies of Treg cells and comparison between groups. The frequency of Treg cells 
was higher in the POAG group (P<0.05) but not in the NPG group, compared to the NC group. Dark blue column: POAG group; 
Light blue column: NPG group; whitr column: NC group. Statistical significance was analyzed using the t test. * P<0.05.
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Th1 frequency was decreased in POAG patients
Unlike Th2 cells, Th1 cells are pertinent to cell immunity. 
Cytokines secreted by Th2 cells can suppress the prolifera-
tion of Th1 cells. Compared to the other 2 groups, the frequen-
cy of Th1 cells was obviously decreased in the POAG group 
(POAG group: 11.95±4.5; NPG group: 16.13±6.41; NC group: 
17.53±6.89; p=0.001; Figure 2). Although the frequency of Th1 
cells was lower in the NPG group than in the NC group, no sig-
nificant difference was observed (p>0.05).
No obvious difference in frequency of Th17 was observed 
between groups
Th17 cells are an important pro-inflammatory component and 
have been shown to promote inflammation in some diseases. 
The proportion of Th17 cells is expressed as the percentage 
of CD4+ T cells. The frequency of Th17 cells was higher in the 
POAG group compared to that in the other groups, but the dif-
ference was not statistically significant (POAG group: 3.04±1.01; 
NPG group: 2.71±1.07; NC group: 2.82±1.65; p=0.624; Figure 2).
Circulating anti-inflammatory Th cells frequencies
Frequency of Treg cells is expressed as CD25+Foxp3+ T cells of 
all CD4+ T cells. As shown in Figure 2, distinctly increased fre-
quency of Treg was only observed in the POAG group, com-
pared to that in the NC group (POAG group: 9.1±2.48; NPG 
group: 6.29±1.74; NC group: 6.53±1.7; p=0.000; Figure 2). No 
significant difference was found between the NPG group and 
NC group (p>0.05)
Serum levels of pro-inflammatory and anti-inflammatory 
cytokines
Th1 cells are characterized by the production and release of 
interferon gamma (IFN-g). The levels of IFN- g in the POAG 
group (24.96±1.94 pg/ml, p<0.05, Figure 1) and the NPG 
group (24.65±1.50 pg/ml, p<0.05) were lower than in the NC 
group (27.33±1.98 pg/ml). Interleukin 4 is the signature cyto-
kine of Th2 cells. The levels of IL-4 were higher in the POAG 
group (15.59±0.87 pg/ml, p>0.05) and especially in the NPG 
group (16.23±0.91 pg/ml, p<0.05), compared to that in the 
NC group (14.87±2.30 pg/ml). The level of IL-17A in the POAG 
group was lower than in the NC group (13.17±1.10 pg/ml vs. 
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Figure 3.  Frequencies of Th1(CD4+IFN-g+ T cells), Th2 (CD4+IL-4+ T cells), and Treg (CD4+CD25+Foxp3+ T cells) cultured for 2 days with 
or without the stimulation of HSP60. (A, D) Frequencies of Treg cells increased more with the stimulation of HSP60 in 
primary open-angle glaucoma patients and normal subjects. In normal-pressure glaucoma patients, no significant increase 
of Treg cells was found after 2-day culture with or without HSP60 stimulation. (B, E) Frequencies of Th2 cells increased more 
significantly with the stimulation of HSP60 in all groups. (C, F) Frequencies of Th1 cells decreased more significantly with the 
stimulation of HSP60 in all groups. POAG – primary open-angle glaucoma; NPG – normal-pressure glaucoma; NC – normal 
control. Dark blue column: basic Th cell frequency; light blue column: Th cell frequency on day 2, without HSP60 stimulation; 
white column: Th cell frequency on day 2, with HSP60 stimulation. Statistical significance was analyzed using a paired t test 
or signed-rank test (n=6). * P<0.05.
1993
Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]  
[ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]  
[Chemical Abstracts/CAS]
Guo C. et al.: 
T helper cell patterns in high-pressure glaucoma and normal-pressure glaucoma
© Med Sci Monit, 2018; 24: 1988-1996
LAB/IN VITRO RESEARCH
This work is licensed under Creative Common Attribution-
NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
14.55±1.98 pg/ml, p<0.05), and no significant decrease was 
observed in the NPG group (13.52±1.08 pg/ml). The level of 
Treg-related cytokines TGF-b1 was higher in the POAG group 
(5.83±1.93 ng/ml) and NPG group (5.21±1.13ng/ml) compared 
to the NC group (3.33±0.59 pg/ml). No significant difference 
was found in the level of IL-10 among groups (3.10±0.75 pg/ml, 
3.05±0.62 pg/ml, 3.03±0.55 pg/ml, p>0.05).
HSP60-induced changes of Th cell frequencies in NPG were 
different from those in POAG and NC
Higher titer of anti-HSP60 was observed only in NPG patients, 
which supports the presence of HSP60 as an antigen in NPG. 
We also observed the different pro- and anti-inflammatory Th 
cell response patterns in POAG and NPG patients. However, it 
was still unknown whether the presence of HSP60 was asso-
ciated with the different Th cell patterns or if they were mere-
ly coexisting in glaucoma patients. Therefore, we stimulated 
PBMCs isolated from patients and normal participants with 
HSP60 for 2 days to observe whether HSP60 would result in Th 
cell response patterns similar to those we had found previous-
ly. Frequencies of Th1, Th2, and Treg cells with or without the 
stimulation of HSP60 are shown in Figure 3. The frequencies 
of Th2 cells increased more significantly with the stimulation 
of HSP60 in POAG, NPG, and NC groups than without HSP60 
stimulation (1.89±0.34 vs. 1.63±0.36, p=0.001; 1.90±0.50 vs. 
1.71±0.47, p=0.007; 1.59±0.17 vs. 1.38±0.20, p=0.001). The fre-
quencies of Th1 cells were lower with the stimulation of HSP60 
in POAG, NPG, and NC groups (3.98±0.85 vs. 4.44±1.02, p=0.028; 
5.29±1.89 vs. 5.61±2.00, p=0.02; 4.79±1.69 vs. 5.14±1.46, 
p=0.021). However, more significantly increased frequencies 
of Treg cells after stimulation of HSP60 were only observed in 
the POAG and NC groups (12.51±1.78 vs. 12.05±1.49, p=0.02; 
10.47±2.28 vs. 9.81±2.24, p=0.012). In the NPG group, no sig-
nificant difference in the frequencies of Treg cells was ob-
served with or without the stimulation of HSP60 (8.52±1.19 
vs. 8.17±1.38, p=0.055), and no significant elevation was ob-
served between basic Treg cell frequency and the frequen-
cy after 2-day culture with HSP60 stimulation (8.37±1.18 vs. 
8.52±1.19, p=0.485).
Discussion
Accumulating evidence on immune response to HSP has been 
found in glaucoma patients and animal models. Investigations 
into the immune pathogenesis may increase the probability 
of finding additional treatments for NPG patients. In 1998, 
Tezel et al. found increased titers of serum antibodies to HSP60 
mainly in NPG patients [19]. In the present study, similar re-
sults were obtained, showing that titers of anti-HSP60 were 
also higher in the NPG group compared to the NC group, and 
no significant difference was observed between the POAG and 
NC groups. It has been reported that greater intensity of im-
munostaining and more labeled cells for HSP60 were found in 
postmortem eyes of POAG and NPG patients [11,24]. If they 
were exposed to the same antigen, why were elevated titers 
of anti-HSP60 found only in the NPG patients?
When confronted with antigens like HSP60, Th cells can dif-
ferentiate into various subpopulations of T cells with specific 
functions and properties, including pro- and anti-inflammato-
ry Th cell subsets. Th1 and Th2 cells are 2 kinds of tradition-
al pro-inflammatory Th cells. Th1 cells are characterized by 
the production and release of IFN-g and are involved in cellu-
lar immune response. Th2 cells are mostly involved in humor-
al immune response and help B cells to produce antibodies. 
Recently, Th17 cells were recognized as a novel subset of pro-
inflammatory Th cells, providing protection against bacterial 
infection. In contrast, Treg cells play an important anti-inflam-
matory role in maintaining the peripheral tolerance, controlled 
by transcription factor Foxp3 and differentiated in response to 
TGF-b [25]. Balanced function of pro- and anti-inflammatory 
components is essential to ensure that the immune response 
is kept under tight control and the chance of developing im-
munopathy is diminished. The imbalance has been found to 
be a pathogenic mechanism leading to the onset of autoim-
mune phenomena, and the abnormal activation of pro-inflam-
matory cells may be associated with deficiencies in the anti-
inflammatory components [26,27].
In our study, significantly activated pro-inflammatory respons-
es were observed in the POAG and NPG groups, compared to 
the NC group. Frequencies of Th2 cells were elevated in the 
POAG and NPG groups, indicating the existence of Th2-driven 
immune response. However, frequencies of Th1 cells were low-
er in both groups than in normal controls. The transcription 
factors of Th2 and Th1 cells – GATA-3 and T-bet – are charac-
terized by mutual antagonism, and the production of IL-4 by 
Th2 antagonizes Th1 polarization. Therefore, decreased Th1 
frequency may also support the activation of Th2-driven im-
mune response. Consistently, higher levels of IL-4 and lower 
levels of IFN-g were found in both glaucoma groups. However, 
significantly increased frequency of the anti-inflammatory com-
ponent – Treg cells – was only found in the POAG group, and 
no significant difference was observed between the NPG and 
NC groups. The importance of Treg cells in the suppression 
of potentially harmful and excessive immune responses has 
been established by many investigations [28], and Treg alter-
ations have been identified in several autoimmune diseases 
such as rheumatoid arthritis and systemic lupus erythemato-
sus [29–31]. It has been reported that Th2 cell-driven immune 
responses are suppressed by Treg cells via a CK2-controlled 
mechanisms or IRF4-controlled mechanisms [32,33]. The lack 
of increased Treg frequency in the NPG group were observed 
together with increased Th2 frequency and higher titers of 
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anti-HSP antibodies, implying that the lack of suppression by 
Treg cells may be ascribed to the increased Th2 cell-driven im-
mune response and consequent RGC apoptosis.
The increased Th2 frequency with decreased Th1 frequency in 
our study is evidence of weakly immunogenic conditions, be-
cause weak antigenic stimulation upregulates expression of 
a transcription factor GATA-3, which in turn drives differentia-
tion of naïve T cells into Th2 effectors. Although Treg cells usu-
ally exert their influence by suppressing the proliferation and 
cytokine production of effector T cells, under steady-state or 
weakly immunogenic conditions, Treg cells act principally to in-
hibit effector function, whereas priming and effector differen-
tiation appears to be unaltered [34,35]. This may explain why 
an increased Th2 frequency without elevated IL-4 was found 
in the peripheral blood of patients in the POAG group. When 
we evaluated Treg-related cytokines – TGF-b1 and IL-10 – the 
levels of these 2 cytokines were not consistent with the altera-
tion in frequencies of Treg cells. TGF-b1 is a very important sup-
pressive cytokine secreted by Treg cells and can induce Foxp3 
expression and a Treg phenotype; however, the serum level of 
TGF-b1 can be influenced by many other factors. Konstas re-
ported that latanoprost monotherapy has a marked effect on 
the aqueous concentration of TGF-b1 [36]. Kuchtey et al. re-
cently reported the significant elevation of systemic TGF-b1 in 
POAG patients as compared to controls [37], which was also 
confirmed in our study. Microfibril deficiencies are associat-
ed with increased TGF-b signaling and higher systemic TGF-b1 
concentrations [38,39], and microfibril genes are reported to 
be associated with glaucoma [40,41], so we hypothesized that 
the microfibril defects lead to elevation of IOP TGF-b1 in glau-
coma patients. Microfibrils are found in the trabecular mesh-
work, the inner wall of Schlemm’s canal, the iris, the ciliary 
body, and in the optic nerve head [42,43]. Thus, the microfi-
bril defects may cause elevation of TGF-b1 in both POAG and 
NPG. The fact that no difference in IL-10 level was observed 
between groups may show that IL-10-secreting CD4+ Treg cells 
are not the primary functioning Treg cells in glaucoma patients.
To further investigate if the pattern of pro- and anti-inflam-
mation Th cells was associated with HSP60, we cultured PBMC 
isolated from POAG and NPG patients and normal participants, 
with or without the stimulation of HSP60 for 2 days. More sig-
nificantly elevated Th2 frequencies were observed with the 
stimulation of HSP60 in all glaucoma patients and normal 
participants. However, in NPG patients, the frequency of Treg 
cells was not obviously elevated after 2 days, with or without 
the HSP60 stimulation, and the Treg cell frequency even de-
creased in 2 patients. Zhou and Dominguez reported that the 
frequency of Treg cells increased because HSP60 can induce 
Treg cells [44,45]. Therefore, our results indicate that HSP60 
can induce Th cell patterns similar to those we had earlier ob-
served in glaucoma patients and normal participants. More 
importantly, in our study, the absence of increased frequen-
cy of Treg cells shows that Treg deficiency might exist in NPG 
patients. This deficiency might lead to an imbalance between 
pro- and anti-inflammatory components, which could conse-
quently cause the activation of Th2-driven immune response 
and elevated titers of anti-HSP60 in NPG patients. Efforts have 
been made to investigate Treg-inducing adjuvant, which may 
be a potential treatment for some NPG patients.
There are 2 main limitations to our study. First, more samples 
are needed to determine whether Treg deficiency exists only 
in the minority of NPG patients or in most of them. Second, 
in vivo experiments with animal models are needed to deter-
mine whether the absence of activated and functional Treg will 
cause NPG-like immune response and RGC loss. Further elu-
cidation of the role of immune responses in glaucoma will in-
spire the discovery of novel pathogenic mechanism and even 
diagnostic and therapeutic strategies in glaucoma.
Conclusions
Different Th cell patterns were observed among POAG, NPG, 
and NC groups. Lack of induction of Treg cells and imbalance 
of the pro-inflammatory and anti-inflammatory response pat-
terns of Th cells exist at least in some NPG patients.
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